Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process

被引:140
|
作者
Abuzar, Sharif Md [1 ,2 ]
Hyun, Sang-Min [1 ,2 ]
Kim, Jun-Hee [1 ,2 ]
Park, Hee Jun [1 ,2 ]
Kim, Min-Soo [3 ]
Park, Jeong-Sook [4 ]
Hwang, Sung-Joo [1 ,2 ]
机构
[1] Yonsei Univ, Coll Pharm, 85 Songdogwahak Ro, Incheon 21983, South Korea
[2] Yonsei Inst Pharmaceut Sci, 85 Songdogwahak Ro, Incheon 21983, South Korea
[3] Pusan Natl Univ, Coll Pharm, 63 Beon Gil 2 Busandaehak Ro, Busan 46241, South Korea
[4] Chungnam Natl Univ, Coll Pharm, 99 Daehak Ro, Daejeon 34134, South Korea
基金
新加坡国家研究基金会;
关键词
Supercritical antisolvent; Poorly water-soluble drug; Solubility; Bioavailability; Micronization; Solid dispersion nanoparticles; IN-VIVO EVALUATION; PARTICLE FORMATION; SOLID DISPERSION; CARBON-DIOXIDE; FLUID ANTISOLVENT; INCLUSION COMPLEX; MASS-TRANSFER; PHYSICOCHEMICAL PROPERTIES; MICRONIZATION PROCESSES; ATORVASTATIN CALCIUM;
D O I
10.1016/j.ijpharm.2017.12.041
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Poor water solubility and poor bioavailability are problems with many pharmaceuticals. Increasing surface area by micronization is an effective strategy to overcome these problems, but conventional techniques often utilize solvents and harsh processing, which restricts their use. Newer, green technologies, such as supercritical fluid (SCF)-assisted particle formation, can produce solvent-free products under relatively mild conditions, offering many advantages over conventional methods. The antisolvent properties of the SCFs used for microparticle and nanoparticle formation have generated great interest in recent years, because the kinetics of the precipitation process and morphologies of the particles can be accurately controlled. The characteristics of the supercritical antisolvent (SAS) technique make it an ideal tool for enhancing the solubility and bioavailability of poorly watersoluble drugs. This review article focuses on SCFs and their properties, as well as the fundamentals of overcoming poorly water-soluble drug properties by micronization, crystal morphology control, and formation of composite solid dispersion nanoparticles with polymers and/or surfactants. This article also presents an overview of the main aspects of the SAS-assisted particle precipitation process, its mechanism, and parameters, as well as our own experiences, recent advances, and trends in development.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 50 条
  • [21] Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs
    Song, Shuangshuang
    Tian, Baocheng
    Chen, Fen
    Zhang, Wenji
    Pan, Yusheng
    Zhang, Qiang
    Yang, Xinggang
    Pan, Weisan
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2015, 41 (01) : 51 - 62
  • [22] Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs
    Kotta, Sabna
    Khan, Abdul Wadood
    Pramod, Kannissery
    Ansari, Shahid H.
    Sharma, Rakesh Kumar
    Ali, Javed
    EXPERT OPINION ON DRUG DELIVERY, 2012, 9 (05) : 585 - 598
  • [23] Using dicationic ionic liquids to upgrade the cytotoxicity and solubility of poorly water-soluble drugs
    Silva A.B.P.
    Jesus A.R.
    Agostinho D.A.S.
    Esperança J.M.S.S.
    Paiva A.
    Duarte A.R.C.
    Reis P.M.
    Journal of Ionic Liquids, 2023, 3 (01):
  • [24] Oral formulation strategies to improve solubility of poorly water-soluble drugs
    Singh, Abhishek
    Worku, Zelalem Ayenew
    Van den Mooter, Guy
    EXPERT OPINION ON DRUG DELIVERY, 2011, 8 (10) : 1361 - 1378
  • [25] Overview of milling techniques for improving the solubility of poorly water-soluble drugs
    Loh, Zhi Hui
    Samanta, Asim Kumar
    Heng, Paul Wan Sia
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 10 (04) : 255 - 274
  • [26] Solubility, the Main Concern for Poorly Water-soluble Drugs: Techniques and Alternatives
    Singh, Komal
    Singh, Preet Amol
    Frank, Amanda
    Arora, Saahil
    Sharma, Rajiv
    Bajwa, Neha
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (12) : 2248 - 2260
  • [27] Supercritical Fluid Particle Design for Poorly Water-soluble Drugs (Review)
    Sun, Yongda
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (03) : 349 - 368
  • [28] Bentonite as a water-insoluble amorphous solid dispersion matrix for enhancing oral bioavailability of poorly water-soluble drugs
    Baek, Min-Jun
    Park, Ju-Hwan
    Nguyen, Duy-Thuc
    Kim, Dahan
    Kim, Jaehwan
    Kang, Il-Mo
    Kim, Dae-Duk
    JOURNAL OF CONTROLLED RELEASE, 2023, 363 : 525 - 535
  • [29] Recrystallization of fluconazole using the supercritical antisolvent (SAS) process
    Park, Hee Jun
    Kim, Min-Soo
    Lee, Sibeum
    Kim, Jeong-Soo
    Woo, Jong-Soo
    Park, Jeong-Sook
    Hwang, Sung-Joo
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 328 (02) : 152 - 160
  • [30] Solubilization of the poorly water soluble drug, telmisartan, using supercritical anti-solvent (SAS) process
    Park, Junsung
    Cho, Wonkyung
    Cha, Kwang-Ho
    Ahn, Junhyun
    Han, Kang
    Hwang, Sung-Joo
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 441 (1-2) : 50 - 55